Viking Therapeutics Announces Pricing of $55.0 Million Public Offering of Common Stock

February 2, 2018

Responsive image

SAN DIEGO, Feb. 2, 2018 /PRNewswire/ — Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the pricing of its public offering of 11,000,000…

Category: Precious Metals